Evidence map›Paper›PMID 32244051›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2021

Lower respiratory tract infection in the community: associations between viral aetiology and illness course.

L M Vos, R Bruyndonckx, N P A Zuithoff, P Little, J J Oosterheert, B D L Broekhuizen, C Lammens, K Loens, M Viveen, C C Butler and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data.The British journal of general practice : the journal of the Royal College of General Practitioners · 2022
    Trial
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Effects ofMolecules (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 4 countries.

L M VosDepartment of Infectious Diseases, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: l.m.vos-6@umcutrecht.nl.
R BruyndonckxLaboratory of Medical Microbiology, Vaccine & Infectious Diseases Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), Hasselt University, Belgium.
N P A ZuithoffJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
P LittlePrimary Care and Population Sciences Unit, University of Southampton, Southampton, UK.
J J OosterheertDepartment of Infectious Diseases, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
B D L BroekhuizenJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
C LammensLaboratory of Medical Microbiology, Vaccine & Infectious Diseases Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium.
K LoensLaboratory of Medical Microbiology, Vaccine & Infectious Diseases Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium.
M ViveenDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
C C ButlerInstitute for Primary Care and Public Health, Cardiff University, Cardiff, UK.
D CrookNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
K ZlatevaDepartment of Medical Microbiology, Leiden University Medical Centre, Leiden University, Leiden, the Netherlands.
H GoossensLaboratory of Medical Microbiology, Vaccine & Infectious Diseases Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BIOSTAT), Hasselt University, Belgium.
E C J ClaasDepartment of Medical Microbiology, Leiden University Medical Centre, Leiden University, Leiden, the Netherlands.
M IevenLaboratory of Medical Microbiology, Vaccine & Infectious Diseases Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium.
A M Van LoonDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
T J M VerheijJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
F E J CoenjaertsDepartment of Medical Microbiology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
GRACE Consortium
Utrecht University · NLUniversity of Antwerp · BELeiden University Medical Center · NLCardiff University · GBUniversity of Oxford · GBUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study determined associations between respiratory viruses and subsequent illness course in primary care adult patients presenting with acute cough and/or suspected lower respiratory tract infection.

methodsA prospective European primary care study recruited adults with symptoms of lower respiratory tract infection between November 2007 and April 2010. Real-time in-house polymerase chain reaction (PCR) was performed to test for six common respiratory viruses. In this secondary analysis, symptom severity (scored 1 = no problem, 2 = mild, 3 = moderate, 4 = severe) and symptom duration were compared between groups with different viral aetiologies using regression and Cox proportional hazard models, respectively. Additionally, associations between baseline viral load (cycle threshold (Ct) value) and illness course were assessed.

resultsThe PCR tested positive for a common respiratory virus in 1354 of the 2957 (45.8%) included patients. The overall mean symptom score at presentation was 2.09 (95% confidence interval (CI) 2.07-2.11) and the median duration until resolution of moderately bad or severe symptoms was 8.70 days (interquartile range 4.50-11.00). Patients with influenza virus, human metapneumovirus (hMPV), respiratory syncytial virus (RSV), coronavirus (CoV) or rhinovirus had a significantly higher symptom score than patients with no virus isolated (0.07-0.25 points or 2.3-8.3% higher symptom score). Time to symptom resolution was longer in RSV infections (adjusted hazard ratio (AHR) 0.80, 95% CI 0.65-0.96) and hMPV infections (AHR 0.77, 95% CI 0.62-0.94) than in infections with no virus isolated. Overall, baseline viral load was associated with symptom severity (difference 0.11, 95% CI 0.06-0.16 per 10 cycles decrease in Ct value), but not with symptom duration.

conclusionsIn healthy, working adults from the general community presenting at the general practitioner with acute cough and/or suspected lower respiratory tract infection other than influenza impose an illness burden comparable to influenza. Hence, the public health focus for viral respiratory tract infections should be broadened.

Indexed as

AdultBelgiumConvalescenceCoronavirusFemaleHumansMaleMetapneumovirusNetherlandsOrthomyxoviridaePrimary Health CareProportional Hazards ModelsProspective StudiesRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsRhinovirusDisease burdenlower respiratory tract infectionprimary healthcarepublic healthrespiratory tract infectionrespiratory virussymptom durationsymptom severity

Identifiers

PMID32244051
PMCPMC7118666
OpenAlexW3013994177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.